Are you Dr. Saviolakis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4301 Jones Bridge Rd
Usuhs Clinical Pharmacology, Bldg 53, Room 109
Bethesda, MD 20814Phone+1 301-295-6434Fax+1 301-295-6519
Summary
- Dr. George Saviolakis, MD is an endocrinologist in Bethesda, Maryland. He is currently licensed to practice medicine in Maryland and Virginia.
Education & Training
Cleveland Clinic FoundationResidency, Internal Medicine, 1972 - 1974
Lakewood HospitalInternship, Internal Medicine, 1971 - 1972
Aristotle University of Thessaloniki School of MedicineClass of 1970
Certifications & Licensure
MD State Medical License 1985 - 2025
VA State Medical License Active through 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B Start of enrollment: 2008 Sep 01
- Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 5 citationsThorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults.Lori M Newman, Martin K. Kankam, Aya Nakamura, Tom Conrad, John D. Mueller
Antimicrobial Agents and Chemotherapy. 2021-10-04 - 4 citationsPhase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers.Mengchun Li, George A Saviolakis, Wael El-Amin, Mamodikoe Makhene, Blaire Osborn
Clinical Pharmacology in Drug Development. 2021-06-01 - 3 citationsHuman Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV).Sumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, Aya Nakamura, Thomas Conrad
The Journal of Infectious Diseases. 2021-01-28
